Perioperative Anti-endotoxin Strategies

REFERENCES

• Jacob AI, Goldberg PH, Bloom D, Degenshein GA, Korin PJ. Endotoxin and bacteria in portal blood. Gastroenterology 1977; 72: 1268–70.
   PubMed Web of Science ®Google Scholar
• Maier RV, Hahnel GB. Microthrombosis during endotoxemia: the role of hepatic versus alveolar macrophages. J Surg Res 1984;36: 362–70.
   PubMed Web of Science ®Google Scholar
• Van Deventer SJH, Buller HR, ten Cate JW, Aarden LA, Hack CE, Sturk A. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic and complement pathways. Blood 1990;76: 2520–7.
   PubMed Web of Science ®Google Scholar
• Morrison DC, Kline LF. Activation of the classical and properdin pathways of complement by bacterial lipopolysac- charides (LPS). J Immunol 1977;118: 362–8.
   PubMed Web of Science ®Google Scholar
• McCabe WR. Serum complement levels in bacteremia due to Gram-negative organisms. N Engl J Med 1973;288: 21–3.
   PubMed Web of Science ®Google Scholar
• Fisher ChJ, Opal SM, Dhainaut JF, Stephens S, Zimmerman JL, Nightingale P, et al. Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. Crit Care Med 1993;21: 318–27.
   PubMed Web of Science ®Google Scholar
• Ziegler EJ, Fisher CJ, Sprung CL, Straube RC, Sadoff JC, Foulke GE, et al. Treatment of Gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin: a randomized, double-blind, placebo controlled trial. N Engl J Med 1991;324: 429–36.
   PubMed Web of Science ®Google Scholar
• Fisher ChJ, Dhainaut J-FA, Opal SM, Pribble JP, Balk RA, Slotman GJ, et al. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. JAMA 1994;271: 1826–43.
   Google Scholar
• Jacob AI, Goldberg PH, Bloom D, Degensheim GA, Korin PJ. Endotoxin and bacteria in portal blood. Gastroenterology 1977;72: 1268–70.
   PubMed Web of Science ®Google Scholar
• Nolan JP. Endotoxin, RES function and liver injury. Hepatology 1981;1: 458–65.
   PubMed Web of Science ®Google Scholar
• Mathison JC, Ulevitch RJ. The clearance, tissue distribution and cellular localization of intravenously injected lipopolysac-charide in rabbits. J Immunol 1979;123: 2133–43.
   PubMed Web of Science ®Google Scholar
• Wilder Baker J, Deitch EA, Berg RD, Specian RD. Hemorrhagic shock induces bacterial translocation from the gut. J Trauma 1988;28: 896–905.
   PubMedGoogle Scholar
• Wilmore DW, Smith RJ, O'Dwuyer ST, Jacobs DO, Ziegler ThR, Xian-Dong Wang. The gut: a central organ after surgical stress. Surgery 1988;104: 917–23.
   PubMed Web of Science ®Google Scholar
• Deitch EA. Intestinal permeability is increased in burn patients shortly after injury. Surgery 1990;107: 411–5.
   PubMed Web of Science ®Google Scholar
• Andersen LW, Landow L, Baek L, Jansen E, Baker S. Association between intramucosal pH and splanchnic endotoxin, antibody to endotoxin, and tumor necrosis factor-α concentrations in patients undergoing cardiopulmonary bypass. Crit Care Med 1993;21: 210–7.
   PubMed Web of Science ®Google Scholar
• O'Dwyer ST, Michie HR, Ziegler ThR, Revhaug A, Smith RJ, Wilmore DW. A single dose of endotoxin increases intestinal permeability in healthy humans. Arch Surg 1988;123: 1459–64.
   PubMedGoogle Scholar
• Biozzi G, Stiffel C. The pathophysiology of the reticuloendothelial cells of the liver and spleen. In: Popper H, editor. Progress in liver disease. New York: Grune & Stratton 1965: 166–91.
   Google Scholar
• Liu YK. Phagocytic capacity of reticuloendothelial system in alcoholics. J Reticuloendothel Soc 1979;25: 605–13.
   PubMedGoogle Scholar
• Nolan JP, Leibowitz Vladutiu AO. Influence of alcohol on Kupffer cell function and possible significance in liver injury. In: Liehr H, Grun M, editor. The reticuloendothelial system and the pathogenesis of liver disease. Amsterdam, Elsevier/North Holland 1980: 125–36.
   Google Scholar
• Thompson JN, Cohen J, Moore RH, Blenkham JI, McConnel JS, Matkin, et al. Endotoxemia in obstructive jaundice. Am J Surg 1988;155: 314–21.
   PubMed Web of Science ®Google Scholar
• Bode C, Fukui H, Bode JC. Hidden endotoxin plasma of patients with alcoholic liver disease. Eur J Gastroenterol Hepatol 1993; 5: 257–62.
   Web of Science ®Google Scholar
• Prytz H, Björneboe M, Örskov F, Hilden M. Antibodies to Escherichia coli in alcoholic and non-alcoholic patients with cirrhosis of the liver and fatty liver. Scand J Gastroenterol 1973;8: 433–8.
   PubMed Web of Science ®Google Scholar
• Nolan JP. The role of endotoxin in liver injury. Gastroenterology 1975;69: 1346–56.
   PubMed Web of Science ®Google Scholar
• Andus T, Bauer J, Gerok W. Effects of cytokines on the liver. Hepatology 1991;13:364–75.
   PubMed Web of Science ®Google Scholar
• Utili R, Abernathy CO, Zimmerman HJ. Studies on the effects of Ecoli endotoxin on canalicular bile formation in the isolated perfused rat liver. J Lab Clin Med 1977;89: 471–82.
   PubMed Web of Science ®Google Scholar
• Van Leeuwen PAM, Hong RW, Rounds JD, Rodrick M, Wilmore DW. Hepatic failure and coma after liver resection is reversed by manipulation of gut contents: the role of endotoxin. Surgery 1991;110: 169–75.
   PubMed Web of Science ®Google Scholar
• Cornell RP. Restriction of gut-derived endotoxin impairs DNA synthesis for liver regeneration. Am J Physiol (Regulatory Integrative Comp. Physiol. 18) 1985;249: R563–9.
   PubMed Web of Science ®Google Scholar
• Van Leeuwen PAM, Boermeester MA, Houdijk APJ, Meyer S, Wesdorp RIC, Rodrick ML, Wilmore DW. Pretreatment with enteral cholestyramine prevents suppression of the cellular immune system after partial hepatectomy. Ann Surg 1995;221: 282–90.
   PubMed Web of Science ®Google Scholar
• Weiss J, Elsbach P, Olsson Odeberg O. Purification and characterization of a potent bacterial and membrane active protein from the granules of human polymorphonuclear leukocytes. J Biol Chem 1978;253: 2664–72.
   PubMed Web of Science ®Google Scholar
• Boermeester MA, Houdijk APJ, Meyer S, Cuesta MA, Appelmelk BJ, Wesdorp RIC, et al. Liver failure induces a systemic inflammatory response: prevention by recombinant N- terminal bactericidal/permeability increasing protein. Am J Pathol 1995;147: 1428–40.
   PubMed Web of Science ®Google Scholar
• Shands JW, Chun PW. The dispersion of Gram-negative lipopolysaccharide by deoxycholate. J Biol Chem 1980;255: 1221–6.
   PubMed Web of Science ®Google Scholar
• Clements WDB, Halliday MI, McCaigue MD, Barclay RG, Rowlands BJ. Effects of extrahepatic obstructive jaundice on Kuppfer cell clearance capacity. Arch Surg 1993;128: 200–5.
   PubMedGoogle Scholar
• Hunt DR, Allison ME, Prentice CR, Blumgart LH. Endotoxemia, disturbance of coagulation and obstructive jaundice. Am J Surg 1982;144: 325–9.
   PubMed Web of Science ®Google Scholar
• Wilkinson SP, Moodie H, Stamatakis JD, Kakkar VV, Williams R. Endotoxemia and renal failure in cirrhosis and obstructive jaundice. Br Med J 1976;2: 1415–8.
   PubMed Web of Science ®Google Scholar
• Ingoldby CJ, McPherson GAD, Blumgart LH. Endotoxemia in human obstructive jaundice. Am J Surg 1984;147: 766–71.
   PubMed Web of Science ®Google Scholar
• Roughneen PT, Kumar SC, Pellis NR, Rowlands BJ. Endotoxemia and cholestasis. Surg Gynecol Obstet 1988;167: 205–10.
   PubMedGoogle Scholar
• Dixon JM, Armstrong CP, Duffy SW, Davies GC. Factors affecting morbidity and mortality after surgery for obstructive jaundice: a review of 373 patients. Gut 1983;24: 845–52.
   PubMed Web of Science ®Google Scholar
• Pitt HA, Cameron JL, Postier RG, Gadacz ThR. factors affecting mortality in biliary tract surgery. Am J Surg 1981;141: 66–72.
   PubMed Web of Science ®Google Scholar
• Greve JW, Gouma DJ, Soeters PB, Buurman WA. Suppression of cellular immunity in obstructive jaundice is caused by endotoxins: a study with germ-free rats. Gastroenterology 1990; 98: 478–85.
   PubMed Web of Science ®Google Scholar
• Pain JA, Bailey ME. Experimental and clinical study of lactulose in obstructive jaundice. Br J Surg 1986;73: 775–8.
   PubMed Web of Science ®Google Scholar
• Liehr H, Englisch G, Rasenack U. Lactulose: A drug with antiendotoxin effect. Hepato-gastroenterology 1980;27: 356–60.
   PubMed Web of Science ®Google Scholar
• Ingoldby CJH. The value of polymyxin B in endotoxemia due to experimental obstructive jaundice and mesenteric ischemia. Br J Surg 1980;67: 565–7.
   PubMed Web of Science ®Google Scholar
• Houdijk APJ, Boermeester MA, Wesdorp RIC, Erik Hack C, van Leeuwen PAM. Tumor necrosis factor unresponsiveness after surgery in bile duct ligated rats. Am J Physiol (Gastrointest Liver Physiol) 1996. In press.
   Google Scholar
• Houdijk APJ, Teerlink T, Bloemers FW, Wesdorp RIC, van Leeuwen PAM. Gut endotoxin restriction prevents catabolic changes in glutamine metabolism after surgery in the bile duct ligated rat. Ann Surg 1997. In press.
   Google Scholar
• Reynolds JV, Murchan P, Redmond HP, Watson RWG, Leonard N, Hill A et al. Failure of macrophage activation in experimental obstructive jaundice: association with bacterial translocation. Br J Surg 1995;82: 534–8.
   PubMed Web of Science ®Google Scholar
• Mackenson A, Galanos C, Wehr U, Engelhardt R. Endotoxin tolerance: regulation of cytokine production and cellular changes in response to endotoxin application in cancer patients. Eur Cytokine Netw 1992;3: 571–9.
   PubMedGoogle Scholar
• Beeson PB. Development of tolerance to typhoid bacterial pyrogen and its abolition by reticuloendothelial blockade. Proc Soc Exp Med 1946;61: 248–50.
   PubMed Web of Science ®Google Scholar
• Greismann SE. Induction of endotoxin tolerance. In: Nowotny A, editor. Beneficial effects of endotoxins. New York: Plenum Press, 1983: 149–78.
   Google Scholar
• Sanchez-Cantu L, Rode HN, Christou NV. Endotoxin tolerance is associated with reduced secretion of tumor necrosis factor. Arch Surg 1989;124: 1432–6.
   PubMedGoogle Scholar
• Bone RC. Pathogenesis of sepsis. Ann Intern Med 1991; 115: 457–69.
   PubMed Web of Science ®Google Scholar
• Svoboda P, Kantorova I, Ochmann J. Dynamics of interleukin 1, 2, 6 and tumor necrosis factor alpha in multiple trauma patients. J Trauma 1994;36: 336–40.
   PubMed Web of Science ®Google Scholar
• Mackenson A, Galanos Ch. Endotoxin tolerance: regulation of cytokine production and cellular changes in response to endotoxin application in cancer patients. Eur Cytokine Netw 1992;3: 571–9.
   PubMedGoogle Scholar
• Flohé S, Heinrich PC, Schneider J, Wendel A, Flohé L. Time course of II-6 and TNFα release during endotoxin-induced endotoxin tolerance in rats. Biochem Pharmacol 1991; 41: 1607–14.
   PubMed Web of Science ®Google Scholar
• Ayala A, Deol ZK, Lehman DL, Herdon CD, Chaudry IH. Does endotoxin play a major role in the depression of macrophage function during polymicrobial sepsis. Arch Surg 1995; 130: 1178–85.
   PubMedGoogle Scholar
• Freudenberg MA, Galanos Ch. Induction of tolerance to lipopolysaccharide (LPS)-D-galactosamine lethality by pretreatment with LPS is mediated by macrophages. Infect Immunol 1988;56: 1352–7.
   PubMed Web of Science ®Google Scholar
• Mathison JC, Virca GD, Wolfson E, Tobias PS, Glaser K, Ulevitch RJ. Adaptation to bacterial lipopolysaccharide controls lipopolysaccharide-induced tumor necrosis factor production in rabbit macrophages. J Clin Invest 1990;85: 1108–18.
   PubMed Web of Science ®Google Scholar
• Zuckerman S, Qureshi N. In vivo inhibition of lipopolysac-charide-induced lethality and tumor necrosis factor synthesis by Rhodobacter sphaeroides diphosphoryl lipid A is dependent on corticosterone induction. Infect Immun 1992;27: 2581–7.
   Google Scholar